UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$336M |
| 2 |
AbbVie
ABBV
|
+$235M |
| 3 |
VMW
VMware, Inc
VMW
|
+$163M |
| 4 |
T-Mobile US
TMUS
|
+$156M |
| 5 |
Aptiv
APTV
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$570M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
Apple
AAPL
|
+$394M |
| 4 |
Abbott
ABT
|
+$262M |
| 5 |
Intel
INTC
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.77% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 13.52% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Waste Management
WM
$96.7B
| $188M | 0.11% |
1,773,905
-206,020
| -10% | -$20.8M |
|
177
Bio-Rad Laboratories Class A
BIO
$8.78B
| $186M | 0.11% |
412,572
+46,288
| +13% | +$20.4M |
|
178
Travelers Companies
TRV
$82.4B
| $186M | 0.11% |
1,629,890
-73,478
| -4% | -$7.74M |
|
|
ALXN
179
DELISTED
Alexion Pharmaceuticals
ALXN
| $186M | 0.11% |
1,652,848
-273,121
| -14% | -$29M |
|
|
WBA
180
DELISTED
Walgreens Boots Alliance
WBA
| $183M | 0.11% |
4,320,764
+751,813
| +21% | +$31.9M |
|
181
Southwest Airlines
LUV
$21.9B
| $183M | 0.11% |
5,356,886
+4,119,346
| +333% | +$131M |
|
|
SRCL
182
DELISTED
Stericycle Inc
SRCL
| $183M | 0.11% |
3,260,757
+131,201
| +4% | +$6.84M |
|
183
Sherwin-Williams
SHW
$84.8B
| $181M | 0.11% |
938,619
-4,281
| -0.5% | -$772K |
|
184
Rockwell Automation
ROK
$50.4B
| $181M | 0.11% |
848,120
+172,279
| +25% | +$33.3M |
|
185
TSMC
TSM
$1.95T
| $179M | 0.11% |
3,149,577
-946,520
| -23% | -$49.9M |
|
186
Equity Residential
EQR
$25.8B
| $179M | 0.11% |
3,037,160
+36,962
| +1% | +$2.29M |
|
187
Illumina
ILMN
$29.1B
| $178M | 0.11% |
494,208
-467
| -0.1% | -$150K |
|
188
MetLife
MET
$62.4B
| $178M | 0.11% |
4,874,406
-117,546
| -2% | -$4.09M |
|
189
LKQ Corp
LKQ
$6.78B
| $178M | 0.11% |
6,784,040
-500,215
| -7% | -$12.3M |
|
190
American Water Works
AWK
$27.2B
| $178M | 0.11% |
1,381,460
-156,984
| -10% | -$19.6M |
|
191
PTC
PTC
$15.1B
| $177M | 0.11% |
2,273,081
-121,587
| -5% | -$8.61M |
|
192
Marvell Technology
MRVL
$148B
| $176M | 0.11% |
5,022,710
-89,460
| -2% | -$2.62M |
|
193
Lockheed Martin
LMT
$133B
| $176M | 0.11% |
481,794
-54,151
| -10% | -$20.5M |
|
|
CTXS
194
DELISTED
Citrix Systems Inc
CTXS
| $175M | 0.11% |
1,185,025
+86,709
| +8% | +$12.5M |
|
195
Cadence Design Systems
CDNS
$93.3B
| $173M | 0.11% |
1,804,920
-238,609
| -12% | -$20M |
|
196
lululemon athletica
LULU
$13.5B
| $173M | 0.11% |
554,559
+79,349
| +17% | +$20.3M |
|
197
Cognizant
CTSH
$26.6B
| $173M | 0.11% |
3,039,282
-320,597
| -10% | -$17.2M |
|
198
Estee Lauder
EL
$30.6B
| $172M | 0.11% |
910,653
-69,342
| -7% | -$12.4M |
|
199
Centene
CNC
$31.3B
| $171M | 0.1% |
2,688,277
-75,953
| -3% | -$4.95M |
|
200
Eaton
ETN
$140B
| $169M | 0.1% |
1,926,425
-87,255
| -4% | -$7.18M |
|
Similar funds
UBS AM's Q2 2020 Portfolio in Review
As of Q2 2020, UBS AM held 2,605 positions worth $164B, up 18% from $139B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
UBS AM withdrew a net $6.16B in Q2 2020, closing 142 positions and reducing 1,290 holdings. Its most notable exit was Allergan plc, an estimated $203M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Otis Worldwide worth $76.5M.
- UBS AM's largest Q2 2020 buy was Otis Worldwide: 1,345,382 shares worth $76.5M.
- UBS AM added most to NetEase in Q2 2020, an estimated $336M increase.
- UBS AM's biggest Q2 2020 reduction was Alibaba, cutting an estimated $570M.
- UBS AM fully exited Allergan plc in Q2 2020, selling an estimated $203M.
- UBS AM's ten largest holdings make up 24% of its $164B portfolio in Q2 2020.
- UBS AM opened 144 new positions and closed 142 in Q2 2020.
- UBS AM's portfolio value rose 18% quarter-over-quarter to $164B.
Based on UBS AM's 13F filing for Q2 2020, filed 14 Aug 2020.